IL-4 INDUCES CHEMOTAXIS OF BLOOD EOSINOPHILS FROM ATOPIC-DERMATITIS PATIENTS, BUT NOT FROM NORMAL INDIVIDUALS

被引:47
作者
DUBOIS, GR
BRUIJNZEELKOOMEN, CAFM
BRUIJNZEEL, PLB
机构
[1] TNO,DEPT PHARMACOL,MED BIOL LAB,2288 GJ RIJSWIJK,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT DERMATOL ALLERGOL,UTRECHT,NETHERLANDS
[3] SWISS INST ALLERGY & ASTHMA RES,DAVOS,SWITZERLAND
关键词
ATOPIC DERMATITIS; CYTOKINES; EOSINOPHILS; MIGRATION; INTERLEUKIN; 4;
D O I
10.1111/1523-1747.ep12382362
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
T lymphocytes present in allergically inflamed tissue synthesize and secrete the cytokines interleukin (IL)-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF). IL-3, IL-5, and GM-CSF, but also IL-4, may act as a chemotaxin on eosinophils. In contrast to the former cytokines, IL-4 is only chemotactic for eosinophils from the peripheral blood of patients with atopic dermatitis and not for eosinophils from normal individuals. IL-4 has the same chemotactic potency as the other cytokines. The optimal chemotactic potency is reached at a concentration of 10 nM. In contrast, neutrophils do not respond chemotactically to IL-4. Checkerboard analysis, inhibition studies with monoclonal anti-IL-4 antibodies, and desensitization experiments indicated specific interaction of IL-4 with eosinophils. In eosinophils from normal individuals, IL-4 responsiveness could be induced by pretreatment of the cells with IL-5 and GM-CSF. In addition to the fact that IL-4 may be responsible for selective eosinophil transendothelial migration, IL-4 may exert an important modulatory mode of action on eosinophil migration and function within allergically inflamed tissue. Our findings suggest the presence of a functional IL-4R on eosinophils from atopic dermatitis patients.
引用
收藏
页码:843 / 846
页数:4
相关论文
共 23 条
  • [11] MOSSMAN TR, 1986, ADV IMMUNOL, V46, P111
  • [12] FIBROBLAST CHEMOTAXIS INDUCTION BY HUMAN RECOMBINANT INTERLEUKIN-4 - IDENTIFICATION BY SYNTHETIC PEPTIDE ANALYSIS OF 2 CHEMOTACTIC DOMAINS RESIDING IN AMINO-ACID-SEQUENCES 70-88 AND 89-122
    POSTLETHWAITE, AE
    SEYER, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2147 - 2152
  • [13] ECZEMATOUS REACTIONS IN ATOPIC PATIENTS CAUSED BY EPICUTANEOUS TESTING WITH INHALANT ALLERGENS
    REITAMO, S
    VISA, K
    KAHONEN, K
    KAYHKO, K
    STUBB, S
    SALO, OP
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (03) : 303 - 309
  • [14] INTERLEUKIN-INDUCED INCREASE IN IA EXPRESSION BY NORMAL MOUSE B-CELLS
    ROEHM, NW
    LIEBSON, HJ
    ZLOTNIK, A
    KAPPLER, J
    MARRACK, P
    CAMBIER, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (03) : 679 - 694
  • [15] DIFFERENTIAL REGULATION OF IGG1 AND IGE SYNTHESIS BY INTERLEUKIN-4
    SNAPPER, CM
    FINKELMAN, FD
    PAUL, WE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) : 183 - 196
  • [16] SPITS H, 1988, J IMMUNOL, V141, P29
  • [17] THORNHILL MH, 1991, J IMMUNOL, V146, P592
  • [18] SKIN-DERIVED AEROALLERGEN-SPECIFIC T-CELL CLONES OF TH2 PHENOTYPE IN PATIENTS WITH ATOPIC-DERMATITIS
    VANREIJSEN, FC
    BRUIJNZEELKOOMEN, CAFM
    KALTHOFF, FS
    MAGGI, E
    ROMAGNANI, S
    WESTLAND, JKT
    MUDDE, GC
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (02) : 184 - 192
  • [19] ATOPIC-DERMATITIS - CORRELATION OF PERIPHERAL-BLOOD T-CELL ACTIVATION, EOSINOPHILIA AND SERUM FACTORS WITH CLINICAL SEVERITY
    WALKER, C
    KAGI, MK
    INGOLD, P
    BRAUN, P
    BLASER, K
    BRUIJNZEELKOOMEN, CAFM
    WUTHRICH, B
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (02) : 145 - 153
  • [20] WALKER C, 1991, J IMMUNOL, V146, P1829